LBG02gkk:g:16000BC12:20000BC02: Difference between revisions

No edit summary
 
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Metabolite
{{Metabolite
|LipidBank=EEL0043
|LipidBank=EEL0043
|SysName=1- [ 2',6'-hydroxysulfonyloxy-D-mannopyranosyl  (a1'-2') -alpha-D-glucopyranosyl ]  2-O- (3'',7'',11'',15''-tetramethyl) hexadecyl-3-O- (3''',7''',11''',15''',19'''-pentamethyl) eicosanyl-sn-glycerol
|SysName=1- [ 2',6'-hydroxysulfonyloxy-D-mannopyranosyl  (a1'-2') -alpha-D-glucopyranosyl ]  2-O- (3'',7'',11'',15''-tetramethyl) hexadecyl-3-O- (3''',7''',11''',15''',19'''-pentamethyl) eicosanyl-sn-glycerol
|Common Name=&&"2,6-di-HSO3-mannosyl glucosyl C20,C25-archaeol"&&
|Common Name=&&2,6-di-HSO3-mannosyl glucosyl C20,C25-archaeol&&
|Mass Spectra={{Image200|LBG02gkk:ggggggggg:16000BC12:20000BC02:01SP0018.gif}} <<0029>>negative FAB, m/z 1227 (M+Na-2H), 1125 (M-SO<SUB><FONT SIZE=-1>3</FONT></SUB>H) <<0029>>,  
|Mass Spectra={{Image200|LBG02gkk:g:16000BC12:20000BC02SP0018.gif}} <<0029>>negative FAB, m/z 1227 (M+Na-2H), 1125 (M-SO_3 H) <<0029>>,  
|IR Spectra={{Image200|LBG02gkk:ggggggggg:16000BC12:20000BC02:01SP0017.gif}}<<0029>>
|IR Spectra={{Image200|LBG02gkk:g:16000BC12:20000BC02SP0017.gif}}<<0029>>
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR {{Image200|LBG02gkk:ggggggggg:16000BC12:20000BC02:01SP0019.gif}}<<0029>><SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>3</FONT></SUP>C-NMR {{Image200|LBG02gkk:ggggggggg:16000BC12:20000BC02:01SP0020.gif}} <<0029>><SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>3</FONT></SUP>C-NMR, 95.74 (C1 of Glc), 74.78 (C2 of Glc), 71.44 (C3 of Glc), 70.14 (C4 of Glc), 72.54 (C5 of Glc), 60.84 (C6 of Glc), 95.66 (C1 of Man), 75.41 (C2 of Man), 69.42 (C3 of Man), 67.76 (C4 of Man), 71.44 (C5 of Man), 66.08 (C6 of Man) <<0029>>,  
|NMR Spectra=^1 H-NMR {{Image200|LBG02gkk:g:16000BC12:20000BC02SP0019.gif}}<<0029>>^{13}C-NMR {{Image200|LBG02gkk:g:16000BC12:20000BC02SP0020.gif}} <<0029>>^{13}C-NMR, 95.74 (C1 of Glc), 74.78 (C2 of Glc), 71.44 (C3 of Glc), 70.14 (C4 of Glc), 72.54 (C5 of Glc), 60.84 (C6 of Glc), 95.66 (C1 of Man), 75.41 (C2 of Man), 69.42 (C3 of Man), 67.76 (C4 of Man), 71.44 (C5 of Man), 66.08 (C6 of Man) <<0029>>,  
|Chromatograms=chromatogram, {{Image200|LBG02gkk:ggggggggg:16000BC12:20000BC02:01CH0012.gif}}<<0029>>TLC, chloroform-methanol-acetic acid-water (85:22.5:10:4, double development) Rf 0.18,  
|Chromatograms=chromatogram, {{Image200|LBG02gkk:g:16000BC12:20000BC02CH0012.gif}}<<0029>>TLC, chloroform-methanol-acetic acid-water (85:22.5:10:4, double development) Rf 0.18,  
}}
}}
{{Lipid/Footer}}

Latest revision as of 21:00, 14 April 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


2,6-di-HSO3-mannosyl glucosyl C20,C25-archaeol
LBG02gkk:g:16000BC12:20000BC02.png
Structural Information
1- [ 2',6'-hydroxysulfonyloxy-D-mannopyranosyl (a1'-2') -α-D-glucopyranosyl ] 2-O- (3,7,11,15-tetramethyl) hexadecyl-3-O- (3,7,11,15,19-pentamethyl) eicosanyl-sn-glycerol
  • 2,6-di-HSO3-mannosyl glucosyl C20,C25-archaeol
Formula
Exact Mass
Average Mass
SMILES
Physicochemical Information
Spectral Information
Mass Spectra
LBG02gkk:g:16000BC12:20000BC02SP0018.gif
<<0029>>negative FAB, m/z 1227 (M+Na-2H), 1125 (M-SO3H) <<0029>>,
UV Spectra
IR Spectra
LBG02gkk:g:16000BC12:20000BC02SP0017.gif
<<0029>>
NMR Spectra 1H-NMR
LBG02gkk:g:16000BC12:20000BC02SP0019.gif
<<0029>>13C-NMR
LBG02gkk:g:16000BC12:20000BC02SP0020.gif
<<0029>>13C-NMR, 95.74 (C1 of Glc), 74.78 (C2 of Glc), 71.44 (C3 of Glc), 70.14 (C4 of Glc), 72.54 (C5 of Glc), 60.84 (C6 of Glc), 95.66 (C1 of Man), 75.41 (C2 of Man), 69.42 (C3 of Man), 67.76 (C4 of Man), 71.44 (C5 of Man), 66.08 (C6 of Man) <<0029>>,
Other Spectra
Chromatograms chromatogram,
LBG02gkk:g:16000BC12:20000BC02CH0012.gif
<<0029>>TLC, chloroform-methanol-acetic acid-water (85:22.5:10:4, double development) Rf 0.18,